🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +21.72% on $IMNM in just 19h 36m.
CVM
$CVM
🔒 US EquitiesCel-Sci Corp
AVG HISTORICAL GAP
+0.41%
MAX GAP RECORD
+4.13%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $CVM
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$CVM
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (UNDETERMINED) |
+0.00%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (AFTER CLOSE) |
+4.13%
|
| Jan 13, 2025 Earnings Release 2025-01-13 (AFTER CLOSE) |
-2.44%
|
| Aug 14, 2024 Earnings Release 2024-08-14 (AFTER CLOSE) |
-0.87%
|
| May 15, 2024 Earnings Release 2024-05-15 (AFTER CLOSE) |
-0.69%
|
| Feb 14, 2024 Earnings Release 2024-02-14 (AFTER CLOSE) |
+0.00%
|
| Dec 21, 2023 Earnings Release 2023-12-21 (AFTER CLOSE) |
+3.75%
|
| Aug 11, 2023 Earnings Release 2023-08-11 (BEFORE OPEN) |
-0.70%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.9%
Bullish Gaps (3)
Bearish Gaps (2)
Neutral / Flat (3)
📖 Intelligence Summary
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗